In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Republicans Block Effort to Check Trump’s Power in Venezuela G.O.P. leaders pressured fellow senators who initially supported the measure, which would have limited President Trump’s military authority ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback